Raab & Moskowitz Asset Management’s Novo Nordisk NVO Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,571	Closed	-$233K	–	190
2025 Q4	$233K	Sell	4,571 -1,310	-22%	-$67K	0.05%	180
2025 Q3	$326K	Sell	5,881 -1,630	-22%	-$95.4K	0.07%	161
2025 Q2	$518K	Buy	+7,511	New	+$511K	0.12%	127
2020 Q1	–	Sell	-500	Closed	-$14K	–	390
2019 Q4	$14K	Buy	+500	New	+$13.8K	0.01%	369
2018 Q4	–	Sell	-500	Closed	-$11K	–	387
2018 Q3	$11K	Buy	+500	New	+$12.2K	﹤0.01%	400
2015 Q1	–	Sell	-1,450	Closed	-$31K	–	297
2014 Q4	$31K	Buy	+1,450	New	+$32.4K	0.02%	234

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Raab & Moskowitz Asset Management's NVO Position: Q1 2026 in Review

Raab & Moskowitz Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,571 shares — an estimated $233K sold.

Raab & Moskowitz Asset Management first reported a position in NVO in Q4 2014 and held it in 6 quarters. The position peaked at $518K in Q2 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Raab & Moskowitz Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 4,571 Novo Nordisk shares in Q1 2026, an estimated $233K.
Raab & Moskowitz Asset Management first reported a position in Novo Nordisk in Q4 2014 and held it in 6 quarters.
Raab & Moskowitz Asset Management's Novo Nordisk position peaked at $518K in Q2 2025.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2026, filed 21 May 2026.